Hook & thesis
Gold Royalty Corp. is finally starting to show the cash flows the market has been waiting for. Record first-quarter 2026 preliminary results - $7.2 million in revenue from 1,920 gold equivalent ounces (GEOs), a 162% year-over-year jump - mean the company's royalty receipts are catching up to its asset growth. Combine that with a cleaned-up capital structure (an upsized US$100 million revolver and elimination of 10% convertible debentures) and the stock at $2.57 is a compelling re-rating candidate if execution continues.
My trade thesis is straightforward: buy Gold Royalty at or near $2.57 on the expectation that the company’s expanding royalty base and near-term production ramps will materially increase cash flow and push valuation closer to peers and prior peaks. The trade is a long-term tactical position intending to capture a re-rating over the next 180 trading days.
What the company does and why the market should care
Gold Royalty is a precious-metals-focused royalty company that provides financing to miners in exchange for royalties on production. That model scales: once you own a royalty you typically get a stream of cash with limited operational risk compared with owning mines outright. The business lever is straightforward - more GEOs produced across the portfolio translates into more royalties and more distributable cash.
Why investors should care now: the company reported record quarterly results on 04/27/2026 showing sharp volume growth (1,920 GEOs, +162% YoY) and reiterated 2026 production guidance of 7,500-9,300 GEOs. Recent portfolio additions (notably the Borborema royalty acquired from Dundee for US$45 million) plus ramping projects at Pedra Branca, Vares, and County Line provide a near-term pathway for material cash-flow growth that has not yet been fully reflected in the share price.
Hard numbers that support the case
- Q1 2026 preliminary revenue: $7.2 million with 1,920 GEOs produced (+162% YoY) - showing meaningful top-line momentum.
- 2026 full-year guidance: 7,500-9,300 GEOs, implying continued scale-up through the year.
- Market cap: $661.61 million and shares outstanding roughly 257.44 million, float ~195.91 million.
- 52-week range: high $5.45 (01/21/2026) and low $2.45 (07/16/2026) - the stock has already retraced heavily from the recent peak.
- Balance sheet improvements: an amended and upsized revolving credit facility of up to US$100 million and elimination of the company's 10% convertible debentures (announced 11/26/2025) reduce financing overhang and cost of capital.
Valuation framing
At a market cap of $661.6 million and 2026 guidance of 7,500-9,300 GEOs the implied market-cap-per-GEO sits between roughly $88,000 and $71,000. That’s a useful, high-level way to think about where the market is pricing future royalty cash flows. The stock currently trades below book (P/B ~ 0.81) and shows a negative PE due to accounting/timing and early-stage cash-flow profiles (PE -325), but Q1’s 162% year-over-year production jump and the growing asset base argue that headline multiples should improve as cash becomes more visible.
Put another way: the company has grown from a small set of royalties in 2021 to 250 assets by 10/01/2025, and the market is pricing that portfolio with skepticism. If the company hits the midpoint of 2026 guidance and the balance sheet remains clean, the shares should re-rate toward higher P/B and a positive PE as recurring royalties replace early-stage volatility.
Technical and market structure notes
- Price action: opening near $2.60 and trading around $2.57 with a recent 10-day simple moving average of $2.572 and 20-day SMA $2.647. The 50-day SMA is higher at $2.894, indicating the stock is still below the medium-term trend.
- Momentum: RSI ~ 40, MACD histogram slightly positive with a bullish momentum reading - suggesting room for upside if catalysts trigger buying.
- Short interest: between ~6.7M and 8.1M shares across recent settlement dates with days-to-cover around 3-4.7 days, and persistent high short volume on trading days. This sets up both a potential squeeze tailwind and heightened volatility risk.
Catalysts (what will drive the re-rating)
- Continued production ramp from newly acquired royalties: Borborema (acquired for US$45M on 01/21/2026) and Pedra Branca additions could materially lift GEO receipts through the rest of 2026.
- Q2 and H1 2026 reported results that confirm cash-flow growth above consensus expectations - quarterly revenue trending meaningfully higher from the $7.2M baseline.
- Disciplined deployment of the US$100M revolver into accretive royalty purchases (or structured royalty financings) rather than equity dilution.
- An uptick in gold prices or sector rotation back into miners and royalty names, which historically compresses required yield and expands multiples for cash-flowing royalty companies.
Trade plan (actionable)
I am recommending a long trade with a clear entry, stop, and target. This is a tactical position that aims to capture a re-rating as cash flow visibility improves.
| Entry | Stop | Target | Horizon |
|---|---|---|---|
| $2.57 | $2.20 | $4.00 | long term (180 trading days) |
Why these levels? Entry at $2.57 captures the current market price, which sits below the stock’s 50-day trend and near a recent low of $2.45. The stop at $2.20 limits downside to a reasonable level if gold prices deteriorate or portfolio production disappoints. The $4.00 target is a conservative re-rating toward the mid-range of the 52-week high range and reflects a scenario where the company meets the midpoint of 2026 guidance, executes accretive bolt-on royalty purchases from the revolver, and the multiples expand toward historical highs.
This trade is intended to last long term (180 trading days) because royalty cash flows and multiple expansion take time to materialize in a name that was in growth mode. Quarterly confirmation of higher revenues and production is the primary timetable driver for the re-rating.
Risks and counterarguments
- Gold-price sensitivity - A sector-wide pullback in the gold price (as occurred in mid-March when gold fell and pressured the stock) will directly hit royalty revenues and can keep multiples compressed even if production ramps as planned.
- Operational execution at partner mines - Royalty companies are exposed to mine operator execution. Delays or lower-grade performance at Pedra Branca, Borborema, Vares, or County Line would reduce GEO deliveries and cash receipts.
- Dilution risk - While the company has improved its capital structure, future equity issuance or share-based consideration for acquisitions could dilute holders and cap upside.
- Valuation complacency - The market has already punished the name from the $5.45 high; if investor sentiment toward junior royalty names remains poor, multiples may not expand even with better cash flow.
- High short-interest driven volatility - Elevated short volume can produce intraday flash moves and increased bid-ask friction; that can blow out stops on weaker days and create whipsaw risk.
Counterargument: The strongest counterargument is that the market (rightly) discounts the company because much of the 250-asset portfolio remains early-stage or dependent on small operators; even with growing GEOs, recurring cash could remain volatile and the company may need to issue equity to fund further growth. If Gold Royalty cannot demonstrate stable quarterly cash inflows or opts for equity-funded acquisitions at weak prices, the re-rating thesis fails and the stock could languish.
What would change my mind
I would downgrade the trade if quarterly reports show repeated missed GEO deliveries relative to guidance, if the company reintroduces high-cost debt or sizeable equity dilution, or if management pivots away from disciplined royalty-generation toward more balance-sheet-risky strategies. Conversely, I would add to the position if Q2 and H1 2026 revenue materially exceed the $7.2M Q1 baseline and if management announces accretive deployments of the US$100M revolver to acquire royalties with immediate cash yield.
Conclusion and stance
Gold Royalty looks like a classic “cash-flow catch-up” situation: the company has assembled a broad portfolio (250 assets), begun to show tangible revenue growth (Q1 2026 revenue of $7.2M and 1,920 GEOs, +162% YoY), and rationalized its balance sheet with a US$100M revolver and the removal of expensive convertible debt. At a market cap of ~$661.6M and a share price around $2.57, I think the setup offers an asymmetric risk-reward for a long-term (180 trading days) trade with a $4.00 target and a $2.20 protective stop.
Execution will be everything: watch quarterly GEO trends, how the revolver is used, and whether underlying operators deliver on production ramps. If those pieces fall into place, multiple expansion should follow and justify the re-rating the market is currently underpricing.
Key dates & references
- Record Q1 2026 preliminary results announced 04/27/2026 (revenue $7.2M, 1,920 GEOs)
- Borborema royalty acquired (Dundee sale closed) 01/21/2026
- Revolver upsized and debentures eliminated announced 11/26/2025
- 250th asset milestone announced 10/01/2025